Drug intelligence / Profile preview

medium-chain triglycerides

Development stage
Unknown
Lead developer
Abian Pharmed
Modality
Small Molecules
Administration
Oral
01

Overview

LiQO OLI is an oral dietary supplement developed and manufactured by Abian Pharmed. It contains medium-chain triglycerides (MCT oil) derived from coconut and palm kernel oils. MCTs are rapidly absorbed and metabolized by the liver, providing an immediate source of energy. LiQO OLI is indicated for the dietary management of individuals with fat malabsorption disorders, malnutrition, chronic liver disease, cystic fibrosis, or those requiring a ketogenic diet (such as patients with drug-resistant epilepsy). It is also utilized by athletes to enhance energy and endurance, and to support weight management.

Brand names
LiQO OLI
Other names
MCT oilmedium chain triglyceridesmedium-chain triacylglycerols
02

Targets

AMPAR (AMPA receptor)PPAR (PPAR family)GPR84FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on medium-chain triglycerides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on medium-chain triglycerides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call